Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	185.82B
Revenue (ttm)	19.11B
Net Income (ttm)	2.44B
Shares Out	209.46M
EPS (ttm)	11.88
PE Ratio	74.66
Forward PE	65.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	261,437
Average Volume	627,498
Open	860.50
Previous Close	860.70
Day's Range	855.25 - 890.25
52-Week Range	636.10 - 943.00
Beta	n/a
RSI	53.54
Earnings Date	Nov 7, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,401
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2024, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.